Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta

Zhang,Hao; Xu,Yang; Yue,Hua; Wang,Chun; Gu,Jiemei; He,Jinwei; Fu,Wenzhen; Hu,Weiwei; Zhang,Zhenlin

doi:10.3892/ijmm.2018.3542

Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta

Authors:
- Hao Zhang
- Yang Xu
- Hua Yue
- Chun Wang
- Jiemei Gu
- Jinwei He
- Wenzhen Fu
- Weiwei Hu
- Zhenlin Zhang
View Affiliations

Affiliations: Department of Osteoporosis and Bone Diseases, Metabolic Bone Diseases and Genetic Research, Shanghai Key Clinical Centre for Metabolic Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
Published online on: March 7, 2018 https://doi.org/10.3892/ijmm.2018.3542
Pages: 3662-3670

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to characterize the clinical manifestations and identify the mutations of Serpin family F member 1 (SERPINF1) and FK506 binding protein 10 (FKBP10) genes in Chinese patients with osteogenesis imperfecta (OI). Using whole‑exome sequencing in the first and third probands, a novel mutation was identified in SERPINF1 and a novel compound heterozygous mutation was revealed in FKBP10. Using Sanger sequencing, an additional novel mutation in SERPINF1 was identified in a proband of family 2. In family 1, the proband presented with a novel homozygous missense mutation of the SERPINF1 gene, c.1067T>A (V356E). In family 2, the proband had a novel homozygous deletion mutation of the SERPINF1 gene, c.283+473_643+104del (p.Ala96_Gly215del). Serum pigment‑epithelium‑derived factor concentration was not detected in probands with OI type VI. For both families, the proband's father was demonstrated to have a heterozygous mutation of SERPINF1, whereas no mutations was detected in the probands' mothers. An assessment of allelic copy numbers revealed a deletion of SERPINF1 in the mother of family 1. The results of the present study demonstrate that patients may have mild symptoms of OI with a large fragment deletion in the SERPINF1 gene. Thus, the phenotype of Chinese patients with type VI OI is milder than that of Caucasian and Korean patients. In family 3, the proband displayed a novel compound heterozygous mutation in FKBP10, c.813_814delGA (p.Glu271AspfsX101) and c.831delC (p.Gly278AlafsX20), and did not have Bruck syndrome. Codon 831 of the FKBP10 gene may represent a mutation hotspot for human OI. These results extend both the phenotypic and the genotypic contents of OI patients with SERPINF1 or FKBP10 mutations.

View Figures

View References

1	Rauch F and Glorieux FH: Osteogenesis imperfecta. Lancet. 363:1377–1385. 2004. View Article : Google Scholar
2	Sillence DO and Rimoin DL: Classification of osteogenesis imperfect. Lancet. 1:1041–1042. 1978. View Article : Google Scholar : PubMed/NCBI
3	Cheung MS and Glorieux FH: Osteogenesis imperfecta: Update on presentation and management. Rev Endoc Metab Disord. 9:153–160. 2008. View Article : Google Scholar
4	Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F and Bishop NJ: Type V osteogenesis imperfecta: A new form of brittle bone disease. J Bone Miner Res. 15:1650–1658. 2000. View Article : Google Scholar : PubMed/NCBI
5	Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ and Travers R: Osteogenesis imperfecta type VI: A form of brittle bone disease with a mineralization defect. J Bone Miner Res. 17:30–38. 2002. View Article : Google Scholar : PubMed/NCBI
6	Tucker T, Nelson T, Sirrs S, Roughley P, Glorieux FH, Moffatt P, Schlade-Bartusiak K, Brown L and Rauch F: A co-occurrence of osteogenesis imperfecta type VI and cystinosis. Am J Med Genet A. 158A. pp. 1422–1426. 2012, View Article : Google Scholar
7	Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, Giunta C, Bergmann C, Rohrbach M, Koerber F, Zimmermann K, et al: Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 88:362–371. 2011. View Article : Google Scholar : PubMed/NCBI
8	Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, et al: Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet. 86:551–559. 2010. View Article : Google Scholar : PubMed/NCBI
9	Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S, Willaert A, Elcioglu N, Van Maldergem L, Verellen-Dumoulin C, et al: Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res. 26:666–672. 2011. View Article : Google Scholar
10	Valadares ER, Carneiro TB, Santos PM, Oliveira AC and Zabel B: What is new in genetics and osteogenesis imperfecta classification? J Pediatr. 90:536–541. 2014. View Article : Google Scholar
11	Zhang ZL, Zhang H, Ke YH, Yue H, Xiao WJ, Yu JB, Gu JM, Hu WW, Wang C, He JW and Fu WZ: The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta. J Bone Miner Metab. 30:69–77. 2012. View Article : Google Scholar
12	Zhang H, Yue H, Wang C, Hu W, Gu J, He J, Fu W, Hu Y, Li M and Zhang Z: Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta. Mol Med Rep. 14:4918–4926. 2016. View Article : Google Scholar : PubMed/NCBI
13	Wang JY, Liu Y, Song LJ, Lv F, Xu XJ, San A, Wang J, Yang HM, Yang ZY, Jiang Y, et al: Novel mutations in SERPINF1 result in rare osteogenesis imperfecta type VI. Calcif Tissue Int. 100:55–66. 2017. View Article : Google Scholar
14	Zhou P, Liu Y, Lv F, Nie M, Jiang Y, Wang O, Xia W, Xing X and Li M: Novel mutations in FKBP10 and PLOD2 cause rare Bruck syndrome in Chinese patients. PloS One. 9:e1075942014. View Article : Google Scholar : PubMed/NCBI
15	Zhang H, He JW, Gao G, Yue H, Yu JB, Hu WW, Gu JM, Hu YQ, Li M, Fu WZ, et al: Polymorphisms in the HOXD4 gene are not associated with peak bone mineral density in Chinese nuclear families. Acta Pharmacol Sin. 31:977–983. 2010. View Article : Google Scholar : PubMed/NCBI
16	Maynard LM, Guo SS, Chumlea WC, Roche AF, Wisemandle WA, Zeller CM, Towne B and Siervogel RM: Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y: The Fels Longitudinal study. Am J Clin Nutr. 68:1111–1117. 1998. View Article : Google Scholar : PubMed/NCBI
17	Lu HK, Zhang Z, Ke YH, He JW, Fu WZ, Zhang CQ and Zhang ZL: High prevalence of vitamin D insufficiency in China: Relationship with the levels of parathyroid hormone and markers of bone turnover. PloS One. 7:e472642012. View Article : Google Scholar : PubMed/NCBI
18	Li R, Li Y, Kristiansen K and Wang J: SOAP: Short oligonucleotide alignment program. Bioinformatics. 24:713–714. 2008. View Article : Google Scholar : PubMed/NCBI
19	Zhang Z, Xia W, He J, Zhang Z, Ke Y, Yue H, Wang C, Zhang H, Gu J, Hu W, et al: Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am J Hum Genet. 90:125–132. 2012. View Article : Google Scholar :
20	Li Y, Vinckenbosch N, Tian G, Huerta-Sanchez E, Jiang T, Jiang H, Albrechtsen A, Andersen G, Cao H, Korneliussen T, et al: Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet. 42:969–972. 2010. View Article : Google Scholar : PubMed/NCBI
21	DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al: A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43:491–498. 2011. View Article : Google Scholar : PubMed/NCBI
22	Wang K, Li M and Hakonarson H: ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
23	Shi Y, Li Y, Zhang D, Zhang H, Li Y, Lu F, Liu X, He F, Gong B, Cai L, et al: Exome sequencing identifies ZNF644 mutations in high myopia. PLoS Genet. 7:e10020842011. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^CT method. Methods. 25:402–408. 2001. View Article : Google Scholar
25	Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, et al: CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 127:291–304. 2006. View Article : Google Scholar : PubMed/NCBI
26	Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, et al: Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med. 355:2757–2764. 2006. View Article : Google Scholar : PubMed/NCBI
27	Willaert A, Malfait F, Symoens S, Gevaert K, Kayserili H, Megarbane A, Mortier G, Leroy JG, Coucke PJ and De Paepe A: Recessive osteogenesis imperfecta caused by LEPRE1 mutations: Clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation. J Med Genet. 46:233–241. 2009. View Article : Google Scholar
28	van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, et al: PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet. 85:521–527. 2009. View Article : Google Scholar : PubMed/NCBI
29	Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR and Byers PH: Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet. 86:389–398. 2010. View Article : Google Scholar : PubMed/NCBI
30	Lapunzina P, Aglan M, Temtamy S, Caparrós-Martín JA, Valencia M, Letón R, Martínez-Glez V, Elhossini R, Amr K, Vilaboa N and Ruiz-Perez VL: Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet. 87:110–114. 2010. View Article : Google Scholar : PubMed/NCBI
31	Li F, Song N, Tombran-Tink J and Niyibizi C: Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: Implication for its role in bone matrix mineralization. J Cell Physiol. 230:1243–1249. 2015. View Article : Google Scholar
32	Homan EP, Rauch F, Grafe I, Lietman C, Doll JA, Dawson B, Bertin T, Napierala D, Morello R, Gibbs R, et al: Mutations in SERPINF1 cause osteogenesis imperfecta type VI. J Bone Miner Res. 26:2798–2803. 2011. View Article : Google Scholar : PubMed/NCBI
33	Venturi G, Gandini A, Monti E, Dalle Carbonare L, Corradi M, Vincenzi M, Valenti MT, Valli M, Pelilli E, Boner A, et al: Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen. J Bone Miner Res. 27:723–728. 2012. View Article : Google Scholar
34	Caparrós-Martin JA, Valencia M, Pulido V, Martínez-Glez V, Rueda-Arenas I, Amr K, Farra C, Lapunzina P, Ruiz-Perez VL, Temtamy S and Aglan M: Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations. Am J Med Genet A. 161A:1354–1369. 2013. View Article : Google Scholar : PubMed/NCBI
35	Cho SY, Ki CS, Sohn YB, Kim SJ, Maeng SH and Jin DK: Osteogenesis imperfecta Type VI with severe bony deformities caused by novel compound heterozygous mutations in SERPINF1. J Korean Med Sci. 28:1107–1110. 2013. View Article : Google Scholar : PubMed/NCBI
36	Rauch F, Husseini A, Roughley P, Glorieux FH and Moffatt P: Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab. 97:E1550–E1556. 2012. View Article : Google Scholar : PubMed/NCBI
37	Steinlein OK, Aichinger E, Trucks H and Sander T: Mutations in FKBP10 can cause a severe form of isolated Osteogenesis imperfecta. BMC Med Genet. 12:1522011. View Article : Google Scholar : PubMed/NCBI
38	Shaheen R, Al-Owain M, Sakati N, Alzayed ZS and Alkuraya FS: FKBP10 and Bruck syndrome: Phenotypic heterogeneity or call for reclassification? Am J Hum Genet. 87:306–307; author reply 308. 2010. View Article : Google Scholar : PubMed/NCBI
39	Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR, Bank RA, Pals G, Ankala A, Conneely K, Seaver L, et al: Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen. Hum Mol Genet. 22:1–17. 2013. View Article : Google Scholar :